Tarvos Capital Management

Description

Tarvos Capital Management is an independent, research-centric, investment management and advisory firm focused mostly on publicly traded and private equities in growth sectors of the medical technology, biotechnology and healthcare services industries. Our investment focus emphasizes companies offering unique platforms or special situations that provide above-average, long-term total returns. We maintain a fundamental research orientation with a strong valuation discipline. Since 2006, Tarvos Capital Management has shared an exclusive research and advisory agreement with Bellevue Asset Management of Zurich, Switzerland.

Tarvos Capital Management is a sole-practitioner investment research and advisory firm that takes minority positions in publicly traded and private equities across medtech, biotech, and healthcare services; it does not acquire or control healthcare-services platforms and is not a buyer of dental practices.

Tarvos Capital Management is a 1-person research and investment advisory firm focused on publicly traded and private equities in medtech, biotech, and healthcare services — it is a minority-stake research/advisory shop, not a platform acquirer or M&A advisor serving healthcare M&A; the Tavily results for 'Tavros Capital' refer to an entirely different NYC real estate firm and are not relevant.

enriched 2026-05-05

Financials